Boston Trust Walden’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$259K Hold
2,140
﹤0.01% 355
2025
Q1
$239K Sell
2,140
-65
-3% -$7.25K ﹤0.01% 360
2024
Q4
$215K Buy
2,205
+42
+2% +$4.09K ﹤0.01% 371
2024
Q3
$249K Buy
2,163
+20
+0.9% +$2.3K ﹤0.01% 358
2024
Q2
$228K Buy
2,143
+44
+2% +$4.68K ﹤0.01% 365
2024
Q1
$203K Hold
2,099
﹤0.01% 369
2023
Q4
$212K Buy
2,099
+84
+4% +$8.48K ﹤0.01% 364
2023
Q3
$205K Hold
2,015
﹤0.01% 356
2023
Q2
$203K Buy
+2,015
New +$203K ﹤0.01% 365
2018
Q2
Sell
-53,077
Closed -$3.85M 380
2018
Q1
$3.85M Sell
53,077
-1,562
-3% -$113K 0.06% 233
2017
Q4
$4.11M Buy
54,639
+4,240
+8% +$319K 0.06% 233
2017
Q3
$3.88M Hold
50,399
0.06% 235
2017
Q2
$3.77M Buy
50,399
+1,340
+3% +$100K 0.06% 234
2017
Q1
$3.27M Buy
49,059
+1,813
+4% +$121K 0.05% 235
2016
Q4
$3.08M Buy
47,246
+28
+0.1% +$1.83K 0.05% 238
2016
Q3
$3.34M Buy
47,218
+2,734
+6% +$193K 0.06% 237
2016
Q2
$3.29M Sell
44,484
-586
-1% -$43.3K 0.06% 241
2016
Q1
$2.93M Buy
45,070
+56
+0.1% +$3.64K 0.05% 246
2015
Q4
$3.47M Sell
45,014
-1,590
-3% -$123K 0.06% 233
2015
Q3
$3.84M Sell
46,604
-2,902
-6% -$239K 0.06% 231
2015
Q2
$4.36M Sell
49,506
-5,189
-9% -$457K 0.07% 226
2015
Q1
$4.83M Sell
54,695
-335
-0.6% -$29.6K 0.07% 221
2014
Q4
$4.57M Buy
55,030
+1,339
+2% +$111K 0.07% 217
2014
Q3
$4.53M Buy
53,691
+56
+0.1% +$4.72K 0.07% 213
2014
Q2
$4.35M Buy
53,635
+18,330
+52% +$1.49M 0.06% 209
2014
Q1
$2.69M Sell
35,305
-497
-1% -$37.9K 0.04% 213
2013
Q4
$2.58M Buy
35,802
+2,227
+7% +$160K 0.04% 216
2013
Q3
$2.31M Buy
33,575
+28,618
+577% +$1.97M 0.04% 216
2013
Q2
$314K Buy
+4,957
New +$314K 0.01% 291